Avanos Medical AVNS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 50%-0.4pp | 50.5%-1.8pp | 52.3%-1.6pp | 53.8%-0.8pp | 54.6%-0.8pp | |
| Operating margin | -9.1%0.0pp | -9.1%+59.8pp | -69%-1.0pp | -68%-11.4pp | -56.6%+1.0pp | |
| Net margin | -10.4%0.0pp | -10.4%+56.6pp | -67%— | —— | —— | |
| EBITDA margin | -3.6%0.0pp | -3.6%+59.6pp | -63.2%-1.4pp | -61.8%-11.6pp | -50.2%+0.8pp | |
| Free cash flow margin | 1.6%-5.1pp | 6.7%-4.6pp | 11.3%-2.0pp | 13.3%-3.2pp | 16.5%+4.5pp | |
| Returns | ||||||
| Return on equity | -9.2%-0.1pp | -9.1%+37.6pp | -46.7%— | —— | —— | |
| Return on assets | -6.9%-0.4pp | -6.5%+27.9pp | -34.4%— | —— | —— | |
| Return on invested capital | -7.5%0.0pp | -7.5%+36.7pp | -44.2%-0.8pp | -43.4%-8.7pp | -34.7%+0.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.6×+0.1× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Inventory turnover | 2.6×+0.1× | 2.4×+0.3× | 2.1×+0.1× | 2.1×0.0× | 2.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.5×+0.3× | 2.2×-0.2× | 2.4×-0.3× | 2.6×+0.1× | 2.6×+0.2× | |
| Quick ratio | 1.4×+0.1× | 1.3×-0.1× | 1.4×-0.2× | 1.6×0.0× | 1.6×0.0× | |
| Cash ratio | 0.5×0.0× | 0.5×+0.1× | 0.5×-0.2× | 0.7×0.0× | 0.7×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -9.1×-0.9× | -8.2×+47.3× | -55.5×-8.9× | -46.6×-11.8× | -34.8×-2.3× | |
| Per Share | ||||||
| Book value per share | $16.47-2.0% | $16.81+0.2% | $16.770.0% | $16.77-6.5% | $17.94-0.4% | |
| Valuation | ||||||
| Market capitalization | $1.17B+108% | $521.28M-2.8% | $536.41M-6.3% | $572.5M-13.2% | $659.23M-9.9% | |
| Enterprise value | $1.24B+105% | $560.58M-6.5% | $599.61M-3.2% | $619.5M-11.9% | $703.13M-11.5% | |
| Price / sales | 1.6×+0.8× | 0.7×0.0× | 0.8×-0.1× | 0.8×-0.1× | 1×-0.1× | |
| Price / book | 1.5×+0.8× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.8×-0.1× | |
| EV / sales | 1.7×+0.9× | 0.8×-0.1× | 0.9×0.0× | 0.9×-0.1× | 1×-0.1× | |
| Free cash flow yield | 1%-19.3pp | 9.1%-5.7pp | 14.7%-1.3pp | 16.1%-1.2pp | 17.3%+6.0pp | |
| Earnings yield | -6.4%+62.1pp | -14%+73.4pp | -87.4%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avanos Medical's profit margins?
- Avanos Medical (AVNS) runs a 50.0% gross margin and a -9.1% operating margin, with a -10.4% net margin.
- Where do Avanos Medical's ratios come from?
- Every ratio is computed from Avanos Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
